Potencjalna przydatność wykrywania krÄ Å¼Ä cych komórek raka stercza w pilotażowej grupie chorych z zaawansowanym rakiem stercza

Prostate cancer is the most common malignancy in developed countries. In recent years, an intense research aimed at finding new markers for prostate cancer treatment regimen to facilitate the selection and control of its effectiveness. The presence of circulating tumor cell population is postulated as a new prognostic and predictive marker for patients with unresectable prostate cancer. The aim of the study was to verify the molecular diagnostic method for the evaluation of circulating prostate cancer cells in metastatic patients in clinical stage.